Papers
9
Total Citations
218
H-Index
7
About
Dr. Paolo Verze is a leading urologic surgeon and researcher whose work centers on advancing robotic-assisted surgery for complex urologic cancers and benign prostatic enlargement. His major contributions include pioneering systematic reviews that define the expanding role of robot-assisted partial nephrectomy (RAPN) for challenging renal masses—such as large tumors (cT2-T3), completely endophytic, hilar, and solitary kidney cases—demonstrating its safety and efficacy with over 55 citations. He has also established evidence-based standards for surgical approaches to large-volume benign prostatic enlargement (BPE), with 48 citations. Dr. Verze’s impact extends to improving oncologic outcomes, as seen in his competing-risk analysis of node-positive prostate cancer survival, and to preserving quality of life through studies on sexual and reproductive outcomes after robot-assisted retroperitoneal lymph node dissection for testicular cancer. Notably, he has addressed the resilience of urology training during the COVID-19 pandemic and investigated factors like prostatic shape for early continence recovery after radical prostatectomy. With over 200 cumulative citations, Dr. Verze’s work is shaping modern urologic practice, making him a key figure in robotic surgery and patient-centered outcomes.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4How Can the COVID-19 Pandemic Lead to Positive Changes in Urology Residency?22 citations · 2020
- 5
- 6
- 7
- 8
- 9